Inovio Awarded up to $56 Million from Epidemic Prevention Coalition to Advance DNA Vaccines Against Lassa Fever and MERS

Inovio Awarded up to $56 Million from Epidemic Prevention Coalition to Advance DNA Vaccines Against Lassa Fever and MERS

Submitted by admin on April 11, 2018 - 11:59pm
Source: 
CP Wire
News Tags: 
Inovio
CEPI
Lassa fever
MERS
Headline: 
Inovio Awarded up to $56 Million from Epidemic Prevention Coalition to Advance DNA Vaccines Against Lassa Fever and MERS
snippet: 

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and CEPI – the Coalition for Epidemic Preparedness Innovations – today announced a partnership under which Inovio will develop vaccine candidates against Lassa fever and Middle East Respiratory Syndrome (MERS).

Do Not Allow Advertisers to Use My Personal information